We're powered by listeners like you. Make a donation to support WBUR.
In Athens, Greece, a tech startup is helping people redistribute their leftover medicine through an app called GivMed.
MIT engineers are using 3D printing and magnets to revolutionize how medical procedures are performed.
Science is under attack from quack experts and self-appointed activists, warns a top doctor who has been caught in the crossfires. He makes the case.
A sociologist questions the ethics of Abilify MyCite, an antipsychotic drug with a built-in digital sensor to monitor adherence.
A professor in reproductive technologies explains the science behind three-parent babies, and why headlines may misconstrue who counts as a parent.
Crimson Education uses an algorithm like eHarmony's to match students with mentors to help them prepare for the application process.
AT&T and Time Warner are merging to create a new media giant.
Here & Now's Robin Young speaks with Peter Kafka, senior editor of media for Recode, about the deal, as well as the official rollback of net neutrality this week.
Many of us could soon find our Internet activities limited to what we can afford to pay for. The good news, writes Miles Howard, is that this doesn’t have to...
Netflix now makes more television than any network in history and the hits keep coming. What’s the secret sauce?
Plastic or the planet? We need to make a choice, or drown in plastic says National Geographic. We’ll dig in.
Artificial intelligence, big data analytics and deep learning are converging on health care in a big way, experts insist.
The biotech industry needs to invest more in developing therapies for childhood diseases, ideally ones that can be given before symptoms arise, writes Geoff McDonough.
With biomedical innovation comes high drug prices. Does pharmaceutical research and development justifies the high cost of today's life-saving drugs?
We speak with Cambridge residents about how the biotech explosion is affecting the city, from swelling rents to -- arguably -- the further corporatization of Harvard Square.
Two new breast cancer studies out this week. One shows that women who receive chemo might not actually need it. The other looks at immunotherapy. We'll discuss.
Telemedicine as the new house call is getting more traction and patients. Is it good medicine?
We look at the history of the biotech industry in Boston.
Here & Now's Robin Young speaks with Kurt Wagner, senior editor at Recode, about what's come out of the Apple conference so far.
From Mad Men to memes, the advertising industry is undergoing epic changes. Bestselling author Ken Auletta shares the inside story.